ARTICLE | Emerging Company Profile

Compass’ range

How Compass’ technology generates large multispecific libraries

August 3, 2018 11:41 PM UTC

Compass Therapeutics LLC combines human cell display, high throughput antibody screening and a multispecific engineering platform to develop large libraries of cancer and autoimmune therapies.

Traditional approaches to antibody discovery use hybridoma fusions in animals, phage display or yeast cell surface display, followed by a humanizing step, which co-founder and CEO Thomas Schuetz said generates smaller libraries of antibodies with less epitopic diversity than Compass’ approach...

BCIQ Company Profiles

Compass Therapeutics Inc.